Arbeitsgruppe Weichteilsarkome - Studien
 
Advanced or metastatic soft tissue sarcoma, first and advanced treatment lines

AIO-Studie   www.clinicaltrials.gov zur Studie

AIO-STS-0415: A randomized phase II study of MEDI4736 and tremelimumab compared to doxorubicin in patients with advanced or metastatic soft tissue sarcoma. MEDISARC
  ---in Rekrutierung---
Gastrointestinal stromal tumor (GIST)

AIO-assoziierte Studie   www.clinicaltrials.gov zur Studie

AIO-STS-0115/ass: Phase 2 trial of ponatinib in patients with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) following failure of prior therapy with imatinib (POETIG trial – POnatinib after rEsisTance to Imatinib in GIST)
  ---in Rekrutierung ---
Gastrointestinal stromal tumor (GIST), adjuvante Therapie

AIO-assoziierte Studie
www.clinicaltrials.gov zur Studie

AIO-STS-0317/ass: Three versus five years of adjuvant imatinib as treatment of patients with operable GIST with a high risk for recurrence: A randomised phase III study
  ---in Rekrutierung ---
Chordome, Knochensarkome, fortgeschrittene Erkrankung

AIO-assoziierte Studie Für weitere Zentren offen  www.clinicaltrials.gov zur Studie

AIO-STS-0217/ass: CDK4/6 inhibition in locally advanced/metastatic chordoma - NCT-PMO-1601
  ---in Rekrutierung ---
Solide Tumore mit DNA-Reparatur Defizienz, fortgeschrittene Erkrankung

AIO-assoziierte Studie Für weitere Zentren offen www.clinicaltrials.gov zur Studie

AIO-STS/TF-0117/ass: Randomized Phase-2 Study of Trabectedin/Olaparib Compared to Physician’s Choice in Subjects with Previously Treated Advanced or Recurrent Solid Tumors Harboring DNA Repair Deficiencies - NCT-PMO-1603
  ---in Rekrutierung---
LETZTE AKTUALISIERUNG DIESER SEITE AM: 25.04.2019